• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胸水细胞学涂片及细胞块检查:对恶性胸腔积液的辅助诊断价值

Examination of cytological smears and cell blocks of pleural fluid: Complementary diagnostic value for malignant effusions.

作者信息

Porcel J M, Quirós M, Gatius S, Bielsa S

机构信息

Pleural Medicine Unit, Arnau de Vilanova University Hospital, Lleida, Spain.

Pleural Medicine Unit, Arnau de Vilanova University Hospital, Lleida, Spain.

出版信息

Rev Clin Esp (Barc). 2017 Apr;217(3):144-148. doi: 10.1016/j.rce.2016.11.004. Epub 2016 Dec 28.

DOI:10.1016/j.rce.2016.11.004
PMID:28038770
Abstract

OBJECTIVES

To evaluate the independent usefulness of pleural fluid smear and cell block (CB) preparations for the diagnosis of malignant effusions.

PATIENTS AND METHODS

A total of 632 cytological smears and 554 CBs from 414 consecutive patients with malignant effusions were retrospectively evaluated.

RESULTS

The diagnostic yield of a first specimen was 44% regardless of whether a smear or CB cytologic examination was performed. The use of subsequent separated specimens increased the identification of malignancy to 56%. Overall, 11% of samples found to be negative by cytologic smears showed malignant cells on CBs, whereas 15% of negative CBs were reported as positive on smear slides. Pleural fluid specimens with low red and/or white blood cell counts more frequently resulted in the generation of suboptimal CB preparations.

CONCLUSIONS

If CBs and smears are prepared and examined, the percentage of positive diagnoses will be greater than if only one method is used.

摘要

目的

评估胸水涂片和细胞块(CB)制备在恶性胸腔积液诊断中的独立应用价值。

患者和方法

回顾性评估了414例连续恶性胸腔积液患者的632份细胞学涂片和554份细胞块。

结果

无论进行涂片还是细胞块细胞学检查,首次标本的诊断阳性率均为44%。使用后续单独的标本可将恶性肿瘤的识别率提高到56%。总体而言,11%的细胞学涂片阴性样本在细胞块中显示有恶性细胞,而15%的细胞块阴性样本在涂片上报告为阳性。红细胞和/或白细胞计数低的胸水标本更常导致细胞块制备效果不佳。

结论

如果同时制备并检查细胞块和涂片,阳性诊断的百分比将高于仅使用一种方法时。

相似文献

1
Examination of cytological smears and cell blocks of pleural fluid: Complementary diagnostic value for malignant effusions.胸水细胞学涂片及细胞块检查:对恶性胸腔积液的辅助诊断价值
Rev Clin Esp (Barc). 2017 Apr;217(3):144-148. doi: 10.1016/j.rce.2016.11.004. Epub 2016 Dec 28.
2
Quality of cell blocks prepared from residual pleural effusion and bronchial washing samples for immunocytochemistry.由残留胸腔积液和支气管冲洗样本制备的用于免疫细胞化学的细胞块的质量。
Cytopathology. 2023 May;34(3):264-270. doi: 10.1111/cyt.13228. Epub 2023 Mar 20.
3
Diagnosis of Pleural Fluid Effusions by Cell Block and Pleural Biopsy - A Comparative Study.通过细胞块和胸膜活检诊断胸腔积液——一项对比研究
J Cytol. 2022 Oct-Dec;39(4):169-173. doi: 10.4103/joc.joc_91_21. Epub 2022 Nov 8.
4
Diagnostic Accuracy of Cell Block and Immunohistochemistry in Effusion Cytology.细胞块及免疫组织化学在积液细胞学诊断中的准确性
Cureus. 2023 Feb 14;15(2):e34958. doi: 10.7759/cureus.34958. eCollection 2023 Feb.
5
The diagnostic yield of pleural fluid cytology in malignant pleural effusions.恶性胸腔积液中胸腔积液细胞学检查的诊断阳性率。
Singapore Med J. 2000 Jan;41(1):19-23.
6
Diagnostic utility of the cell block method versus the conventional smear study in pleural fluid cytology.细胞块法与传统涂片检查在胸腔积液细胞学诊断中的应用价值
J Cytol. 2012 Jan;29(1):11-5. doi: 10.4103/0970-9371.93210.
7
A comparative study of conventional cytology and cell block method in the diagnosis of pleural effusion.传统细胞学与细胞块法在胸腔积液诊断中的对比研究。
J Thorac Dis. 2017 Sep;9(9):3161-3167. doi: 10.21037/jtd.2017.08.52.
8
The cell block method increases the diagnostic yield in exudative pleural effusions accompanying lung cancer.细胞块法可提高肺癌伴发渗出性胸腔积液的诊断阳性率。
Turk Patoloji Derg. 2013;29(3):165-70. doi: 10.5146/tjpath.2013.01184.
9
The value of exfoliative cell cytology in the diagnosis of exudative pleural effusions.脱落细胞细胞学检查在渗出性胸腔积液诊断中的价值。
Monaldi Arch Chest Dis. 2018 Sep 11;88(3):944. doi: 10.4081/monaldi.2018.944.
10
Clinicopathological Study of 117 Body Fluids: Comparison of Conventional Smear and Cell Block Technique.117份体液的临床病理研究:传统涂片与细胞块技术的比较
Curr Health Sci J. 2020 Oct-Dec;46(4):336-343. doi: 10.12865/CHSJ.46.04.03. Epub 2020 Dec 31.

引用本文的文献

1
The combination of cytospin Diff-Quik and conventional cytological examination increases the diagnostic yield for malignant pleural effusion.细胞离心涂片Diff-Quik染色法与传统细胞学检查相结合可提高恶性胸腔积液的诊断率。
ERJ Open Res. 2025 Jun 2;11(3). doi: 10.1183/23120541.00856-2024. eCollection 2025 May.
2
Malignant Pleural Effusion: A Multidisciplinary Approach.恶性胸腔积液:多学科治疗方法
Open Respir Arch. 2024 Jun 19;6(4):100349. doi: 10.1016/j.opresp.2024.100349. eCollection 2024 Oct-Dec.
3
Diagnostic analysis of pleural fluid cell blocks using relevant immunohistochemical markers in clinically suspicious cases of malignancy.
在临床怀疑为恶性肿瘤的病例中,使用相关免疫组化标志物对胸腔积液细胞块进行诊断分析。
Cytojournal. 2024 Feb 9;21:8. doi: 10.25259/Cytojournal_40_2023. eCollection 2024.
4
Malignant Pleural Effusions: Updates in Diagnosis and Management.恶性胸腔积液:诊断与治疗的新进展
Life (Basel). 2022 Dec 31;13(1):115. doi: 10.3390/life13010115.
5
Sensitivity and complications of thoracentesis and thoracoscopy: a meta-analysis.胸腔穿刺和胸腔镜检查的敏感性和并发症:一项荟萃分析。
Eur Respir Rev. 2022 Dec 21;31(166). doi: 10.1183/16000617.0053-2022. Print 2022 Dec 31.
6
Diagnosis and Management of Malignant Pleural Effusion: A Decade in Review.恶性胸腔积液的诊断与管理:十年回顾
Diagnostics (Basel). 2022 Apr 18;12(4):1016. doi: 10.3390/diagnostics12041016.
7
Diving into the Pleural Fluid: Liquid Biopsy for Metastatic Malignant Pleural Effusions.深入研究胸腔积液:转移性恶性胸腔积液的液体活检
Cancers (Basel). 2021 Jun 4;13(11):2798. doi: 10.3390/cancers13112798.
8
Architectural aspects of cell-blocks as small biopsies.作为小活检样本的细胞块的结构特征。
Cytojournal. 2021 Mar 4;18:5. doi: 10.25259/Cytojournal_4_2021. eCollection 2021.
9
Contribution of Cell Block Obtained by Thoracentesis in the Diagnosis of Malignant Pleural Effusion.胸腔穿刺获得的细胞块在恶性胸腔积液诊断中的作用
J Cytol. 2019 Oct-Dec;36(4):205-208. doi: 10.4103/JOC.JOC_99_18. Epub 2019 Jun 11.
10
Biomarkers in the diagnosis of pleural diseases: a 2018 update.胸腔疾病诊断中的生物标志物:2018 年更新。
Ther Adv Respir Dis. 2018 Jan-Dec;12:1753466618808660. doi: 10.1177/1753466618808660.